Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1992 1
1995 1
1996 5
1997 6
1998 5
1999 2
2000 9
2001 15
2002 18
2003 28
2004 26
2005 42
2006 39
2007 64
2008 42
2009 21
2010 25
2011 17
2012 17
2013 19
2014 14
2015 16
2016 14
2017 15
2018 22
2019 9
2020 11
2021 9
2022 12
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 17663389

487 results

Results by year

Filters applied: . Clear all
Page 1
Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.
Bishop MR, Hou JW, Wilson WH, Steinberg SM, Odom J, Castro K, Kasten-Sportes C, Gea-Banacloche J, Marchigiani D, Gress R, Fowler DH. Bishop MR, et al. Biol Blood Marrow Transplant. 2003 Mar;9(3):162-9. doi: 10.1053/bbmt.2003.50008. Biol Blood Marrow Transplant. 2003. PMID: 12652466 Free article. Clinical Trial.
Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H. Liu QF, et al. Biol Blood Marrow Transplant. 2009 Nov;15(11):1376-85. doi: 10.1016/j.bbmt.2009.06.017. Epub 2009 Aug 19. Biol Blood Marrow Transplant. 2009. PMID: 19822296 Free article. Clinical Trial.
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR. Schütt P, et al. Eur J Haematol. 2007 Feb;78(2):93-101. doi: 10.1111/j.1600-0609.2006.00796.x. Eur J Haematol. 2007. PMID: 17313557 Clinical Trial.
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.
Corradini P, Dodero A, Zallio F, Caracciolo D, Casini M, Bregni M, Narni F, Patriarca F, Boccadoro M, Benedetti F, Rambaldi A, Gianni AM, Tarella C. Corradini P, et al. J Clin Oncol. 2004 Jun 1;22(11):2172-6. doi: 10.1200/JCO.2004.12.050. J Clin Oncol. 2004. PMID: 15169805 Clinical Trial.
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.
Buser AS, Stern M, Bucher C, Arber C, Heim D, Halter J, Meyer-Monard S, Stussi G, Lohri A, Ghielmini M, Tichelli A, Passweg JR, Gratwohl A. Buser AS, et al. Bone Marrow Transplant. 2007 Mar;39(6):335-40. doi: 10.1038/sj.bmt.1705597. Bone Marrow Transplant. 2007. PMID: 17342158 Clinical Trial.
Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.
Woessmann W, Peters C, Lenhard M, Burkhardt B, Sykora KW, Dilloo D, Kremens B, Lang P, Führer M, Kühne T, Parwaresch R, Ebell W, Reiter A. Woessmann W, et al. Br J Haematol. 2006 Apr;133(2):176-82. doi: 10.1111/j.1365-2141.2006.06004.x. Br J Haematol. 2006. PMID: 16611309 Free article.
487 results